Reviva Pharmaceuticals Holdings Inc. (RVPH)
Official siteHEALTHCARE • BIOTECHNOLOGY • PINK
Market Cap: $4.63M
Last updated: Nov 13, 2026 at 4:00 PM ET
Reviva Pharmaceuticals Holdings Inc. (RVPH) Earnings: Report Dates and Results
In the quarter ended Sep 30, 2026, Reviva Pharmaceuticals Holdings reported EPS of -$0.17, above the -$0.18 estimate. It beat the EPS estimate in 4 of the 8 most recent quarters that had an estimate.
Earnings
Performance (10Y)
Upcoming Estimates
Next Report
RVPH's report for the quarter ending Dec 31, 2026 is not on the earnings calendar yet.
Earnings History
Of the 24 quarters below that had an estimate, RVPH beat 11, missed 9 and matched 4. The widest gap in the table came in the quarter ended Dec 31, 2024, when EPS landed 300.00% below the estimate.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported |
|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | -$0.17 | -$0.18 | -$0.18 - -$0.18 | +5.56% | Beat | N/A | 1 | 1 up, 0 down | Nov 12, 2026 |
| Jun 30, 2026 | -$0.19 | -$0.41 | -$0.41 - -$0.41 | +53.66% | Beat | N/A | 1 | 0 up, 1 down | Aug 12, 2026 |
| Mar 31, 2026 | -$0.46 | -$0.29 | -$0.29 - -$0.29 | -58.62% | Miss | N/A | 2 | 2 up, 0 down | May 14, 2026 |
| Dec 31, 2025 | -$5.19 | -$0.07 | N/A | N/A | N/A | N/A | 6 | 1 up, 0 down | Mar 30, 2026 |
| Sep 30, 2025 | -$1.20 | -$1.94 | -$2.60 - -$0.80 | +38.14% | Beat | N/A | 7 | 1 up, 0 down | Nov 13, 2025 |
| Jun 30, 2025 | -$2.40 | -$2.20 | -$2.80 - -$1.60 | -9.09% | Miss | N/A | 4 | 2 up, 0 down | Aug 14, 2025 |
| Mar 31, 2025 | -$2.60 | -$3.65 | -$4.00 - -$3.40 | +28.77% | Beat | N/A | 4 | 3 up, 0 down | May 15, 2025 |
| Dec 31, 2024 | -$0.90 | -$0.23 | -$0.25 - -$0.19 | -300.00% | Miss | N/A | 5 | 0 up, 0 down | Mar 31, 2025 |
| Sep 30, 2024 | -$5.00 | -$5.00 | -$6.20 - -$4.00 | 0.00% | In line | N/A | 4 | 2 up, 0 down | Nov 14, 2024 |
| Jun 30, 2024 | -$5.20 | -$6.20 | -$6.20 - -$5.40 | +16.13% | Beat | N/A | 4 | 0 up, 0 down | Aug 14, 2024 |
| Mar 31, 2024 | -$5.00 | -$7.53 | -$9.20 - -$5.60 | +33.60% | Beat | N/A | 3 | 1 up, 0 down | Apr 15, 2024 |
| Dec 31, 2023 | -$0.35 | -$0.35 | -$0.38 - -$0.29 | 0.00% | In line | N/A | 4 | 0 up, 0 down | Mar 19, 2024 |
| Sep 30, 2023 | -$8.80 | -$7.75 | -$10.60 - -$5.00 | -13.55% | Miss | N/A | 5 | 0 up, 0 down | Nov 14, 2023 |
| Jun 30, 2023 | -$11.00 | -$5.00 | -$6.80 - -$4.40 | -120.00% | Miss | N/A | 5 | 0 up, 0 down | Aug 14, 2023 |
| Mar 31, 2023 | -$6.00 | -$5.80 | -$7.20 - -$5.80 | -3.45% | Miss | N/A | 2 | 0 up, 0 down | May 15, 2023 |
| Dec 31, 2022 | -$0.38 | -$0.22 | -$0.27 - -$0.19 | -72.73% | Miss | N/A | 4 | 0 up, 0 down | Mar 30, 2023 |
| Sep 30, 2022 | -$3.60 | -$5.20 | -$6.00 - -$5.20 | +30.77% | Beat | N/A | 3 | 0 up, 0 down | Nov 14, 2022 |
| Jun 30, 2022 | -$5.80 | -$7.00 | N/A | +17.14% | Beat | N/A | N/A | 0 up, 0 down | Aug 15, 2022 |
| Mar 31, 2022 | -$8.00 | -$5.00 | N/A | -60.00% | Miss | N/A | 1 | 0 up, 0 down | May 16, 2022 |
| Dec 31, 2021 | -$0.22 | -$0.25 | -$0.27 - -$0.22 | +12.00% | Beat | N/A | 3 | 1 up, 0 down | Mar 15, 2022 |
| Sep 30, 2021 | -$2.40 | -$4.60 | -$5.00 - -$4.40 | +47.83% | Beat | N/A | 2 | 0 up, 0 down | Nov 15, 2021 |
| Jun 30, 2021 | -$2.40 | -$4.80 | N/A | +50.00% | Beat | N/A | N/A | N/A | Aug 16, 2021 |
| Mar 31, 2021 | -$0.10 | -$0.10 | N/A | 0.00% | In line | N/A | N/A | N/A | May 17, 2021 |
| Dec 31, 2020 | -$3.30 | -$1.20 | N/A | -175.00% | Miss | -6700.0% | N/A | N/A | Mar 22, 2021 |
| Sep 30, 2020 | -$0.04 | -$0.04 | N/A | 0.00% | In line | -136.4% | N/A | N/A | Dec 2, 2020 |
| Jun 30, 2020 | -$0.06 | N/A | N/A | N/A | N/A | -146.2% | N/A | N/A | Jul 7, 2020 |
| Mar 31, 2020 | -$0.05 | N/A | N/A | N/A | N/A | -101.9% | N/A | N/A | May 1, 2020 |
| Dec 31, 2019 | $0.05 | N/A | N/A | N/A | N/A | -93.3% | N/A | N/A | Jan 10, 2020 |
| Sep 30, 2019 | $0.11 | N/A | N/A | N/A | N/A | -94.6% | N/A | N/A | Oct 8, 2019 |
| Jun 30, 2019 | $0.13 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Jul 3, 2019 |
| Mar 31, 2019 | $2.60 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | May 22, 2019 |
| Dec 31, 2018 | $0.74 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Jan 9, 2019 |
| Sep 30, 2018 | $2.03 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Oct 11, 2018 |
Annual EPS
EPS for the fiscal year ended Dec 31, 2025 was -$11.39, after -$16.10 the year before. It was $2.77 for the year ended Dec 31, 2018, the oldest of the 8 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Dec 31, 2025 | -$11.39 | N/A |
| Dec 31, 2024 | -$16.10 | N/A |
| Dec 31, 2023 | -$26.15 | N/A |
| Dec 31, 2022 | -$17.78 | N/A |
| Dec 31, 2021 | -$5.12 | N/A |
| Dec 31, 2020 | -$3.45 | -219.3% |
| Dec 31, 2019 | $2.89 | +4.4% |
| Dec 31, 2018 | $2.77 | N/A |
Frequently Asked Questions About RVPH
Did RVPH beat earnings estimates last quarter?
Yes. Reviva Pharmaceuticals Holdings reported EPS of -$0.17 for the quarter ended Sep 30, 2026, above the -$0.18 estimate, a 5.56% surprise.
What EPS do analysts expect from RVPH next quarter?
The consensus EPS estimate for Reviva Pharmaceuticals Holdings for the quarter ending Dec 31, 2026 is -$0.74 from 8 analysts, with estimates from -$1.37 to -$0.10.
How often does RVPH beat earnings estimates?
Reviva Pharmaceuticals Holdings beat the EPS estimate in 4 of the 8 most recent quarters that had an estimate, with an average surprise of -30.20%.
RVPH pages: Overview, Earnings, Forecast, Financials, Competitors